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Abstract
Background: The population of HIV replicating within a host consists of independently evolving and interacting
sub-populations that can be genetically distinct within anatomical compartments. HIV replicating within the brain
causes neurocognitive disorders in up to 20-30% of infected individuals and is a viral sanctuary site for the
development of drug resistance. The primary determinant of HIV neurotropism is macrophage tropism, which is
primarily determined by the viral envelope (env) gene. However, studies of genetic aspects of HIV replicating in the
brain are hindered because existing repositories of HIV sequences are not focused on neurotropic virus nor
annotated with neurocognitive and neuropathological status. To address this need, we constructed the HIV Brain
Sequence Database.
Results: The HIV Brain Sequence Database is a public database of HIV envelope sequences, directly sequenced
from brain and other tissues from the same patients. Sequences are annotated with clinical data including viral
load, CD4 count, antiretroviral status, neurocognitive impairment, and neuropathological diagnosis, all curated from
the original publication. Tissue source is coded using an anatomical ontology, the Foundational Model of Anatomy,
to capture the maximum level of detail available, while maintaining ontological relationships between tissues and
their subparts. 44 tissue types are represented within the database, grouped into 4 categories: (i) brain, brainstem,
and spinal cord; (ii) meninges, choroid plexus, and CSF; (iii) blood and lymphoid; and (iv) other (bone marrow,
colon, lung, liver, etc). Patient coding is correlated across studies, allowing sequences from the same patient to be
grouped to increase statistical power. Using Cytoscape, we visualized relationships between studies, patients and
sequences, illustrating interconnections between studies and the varying depth of sequencing, patient number,
and tissue representation across studies. Currently, the database contains 2517 envelope sequences from 90
patients, obtained from 22 published studies. 1272 sequences are from brain; the remaining 1245 are from blood,
lymph node, spleen, bone marrow, colon, lung and other non-brain tissues. The database interface utilizes a
faceted interface, allowing real-time combination of multiple search parameters to assemble a meta-dataset, which
can be downloaded for further analysis.
Conclusions: This online resource, which is publicly available at http://www.HIVBrainSeqDB.org, will greatly
facilitate analysis of the genetic aspects of HIV macrophage tropism, HIV compartmentalization and evolution
within the brain and other tissue reservoirs, and the relationship of these findings to HIV-associated neurological
disorders and other clinical consequences of HIV infection.
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The population of HIV replicating within a host consists
of independently evolving and interacting sub-popula-
tions, as demonstrated by the various degrees of phylo-
genetic compartmentalization seen across and within
anatomical compartments and various rates of decay in
viral load during HAART therapy [1,2]. Several factors
contribute to this genetic compartmentalization: (i) viral
target cell tropism–HIV infects CD4+ T cells and
macrophages in the periphery, and primarily infects
macrophages and microglia (and rarely, astrocytes) in
the brain [3]; (ii) viral adaptation in response to immune
selection pressures that differ between anatomical com-
partments [3,4]; (iii) physical barriers such as the blood-
brain barrier [5]; and (iv) variable antiretroviral drug
penetration into different tissues [6,7]. An important
viral sub-population is HIV replicating within the brain
[8-10]. HIV replicating in the brain causes neurocogni-
tive and neuropathological disorders in up to 20-30% of
infected individuals, particularly in later stages of dis-
ease; in the era of HAART, HIV-associated neurocogni-
tive disorders (HAND) have emerged as a significant
cause of mortality and morbidity [4,6]. Additionally, the
brain is a sanctuary site for the development of drug
resistance, because poor antiretroviral drug penetration
into the CNS leads to sub-therapeutic drug concentra-
tions and incomplete suppression of viral replication [6].
The primary determinant of HIV neurotropism is
macrophage tropism, which is primarily determined by
genetic variation in the viral envelope (env)g e n e[ 8 ] .
Phylogenetically related populations of macrophage-tro-
pic virus are found across brain and other macrophage-
rich tissues, such as lung and bone marrow [11,12].
Thus, studies of the genetics of HIV replicating in the
brain are pertinent to important clinical aspects of HIV,
as well as the biology of the virus replicating within spe-
cific anatomical compartments.
There are several excellent existing repositories of
HIV sequences in the public domain, two of the most
widely used being Genbank at the NCBI [13] and the
HIV Sequence Database at the Los Alamos National
Laboratory (LANL) (http://hiv.lanl.gov). However,
neither is focused on neurotropic virus nor contains
clinical annotations of neurocognitive and neuropatholo-
gical diagnosis. Though more than 20 publications have
clonally sequenced HIV env from the brain, assembling
a meta-dataset of these sequences presents significant
technical challenges. To address these challenges, we
constructed the HIV Brain Sequence Database (HBSD),
the first comprehensive database of HIV envelope
sequences clonally sequenced from brain and non-brain
tissues, which is publicly available at http://HIVBrain-
SeqDB.org
The HIV Brain Sequence Database
The HBSD contains 2517 envelope sequences from 90
patients. Sequences were obtained from 22 published
studies (Table 1) ranging in publication date from 1991
to 2009 and in number of sequences per publication
from 1 to over 700. 1272 of these sequences are brain-
derived; the remaining approximately 1245 are derived
from blood, lymph node, spleen, bone marrow, colon,
lung and other non-brain tissues. 44 independent tissue
types are represented within the database. These tissue
types are grouped into 4 categories: (i) brain, brainstem,
and spinal cord; (ii) meninges, choroid plexus, and CSF;
(iii) blood and lymphoid; and (iv) other (bone marrow,
lung, liver, etc) (Table 2). Figure 1 shows the database
sequence content aligned to the env gene of HXB2. V3
region and near full-length gp120 region sequences
comprise the majority of the database, with approxi-
mately 1100 and 800 sequences, respectively. There are
also approximately 200 near full-length env sequences,
150 V4-V5 region, and 100 V1-V2 region. As new publi-
cations emerge, facilitated by new sequencing technolo-
g i e s ,w ee x p e c tt h es i z eo ft h eH B S Dt of o l l o wt h e
Table 1 Publications describing the cloning of sequences
included in the HBSD
Publication Number of Sequences
Keele, Burton (2008) [19] 51
Power, Chesebro (1994) [20] 15
Peters, Clapham (2004) [21] 31
Mefford, Gabuzda (unpublished) 33
Mefford, Gabuzda (2008) [22] 10
Ohagen, Gabuzda (2003) [23] 35
Thomas, Gabuzda (2007) [24] 55
Liu, Gartner (2000) [25] 31
Martín-García, González-Scarano (2006) [26] 12
Shapshak, Goodkin (1999) [15] 65
Li, Hahn (1991) [27] 2
Gatanaga, Iwamoto (1999) [28] 17
Lamers, McGrath (2009) [29] 715
Salemi, McGrath (2005) [12] 88
Shah, Saksena (2006) [30] 30
Smit, Saksena (2001) [31] 11
Hughes, Simmonds (1997) [32] 87
McCrossan, Simmonds (2006) [18] 259
Morris, Simmonds (1999) [33] 252
Wang, Simmonds (2001) [11] 470
Monken, Srinivasan (1995) [34] 39
Korber, Wolinsky (1994) [17] 209
First author, last author and publication year of included publications, sorted
by last author is shown in the left column. Total number of sequences
included in the database from each publication is shown in the right column.
In some cases, publications may contain additional sequences that did not
meet our inclusion criteria–for example, sequences from isolates or patients
with no brain sequences–and were therefore omitted.
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Page 2 of 12Table 2 Classification of tissues represented in the database, with their respective Foundational Model of
Anatomy (FMA) codes
Brain, brainstem, and spinal cord (n = 1272) FMA Code Number of sequences
Brain FMA:50801 171
Brainstem FMA:79876 16
Caudate nucleus FMA:61833 7
Cortex of frontal lobe FMA:242199 67
Cortex of occipital lobe FMA:242205 20
Cortex of temporal lobe FMA:242201 77
Frontal lobe FMA:61824 91
Left frontal lobe FMA:72970 214
Left hemisphere of cerebellum FMA:83877 1
Left occipital lobe FMA:72976 12
Left parietal lobe FMA:72974 5
Left temporal lobe FMA:72972 17
Middle frontal gyrus FMA:61859 10
Occipital lobe FMA:67325 25
Parietal lobe FMA:61826 3
Putamen FMA:61834 1
Right frontal lobe FMA:72969 43
Right hemisphere of cerebellum FMA:83876 1
Right occipital lobe FMA:72975 16
Right parietal lobe FMA:72973 18
Right temporal lobe FMA:72971 15
Set of basal ganglia FMA:84013 87
Spinal cord FMA:7647 12
Temporal lobe FMA:61825 41
White matter of frontal lobe FMA:256178 111
White matter of neuraxis FMA:83929 29
White matter of occipital lobe FMA:256188 140
White matter of temporal lobe FMA:256186 22
Meninges, choroid plexus, and CSF (n = 184)
Choroid plexus of cerebral hemisphere FMA:61934 44
CSF FMA:20935 1
Set of meninges FMA:76821 139
Blood and lymphoid (n = 776)
Blood FMA:9670 122
Infraclavicular lymph node FMA:14193 4
Lymph node FMA:5034 417
Mesenteric lymph node FMA:12795 28
Peripheral blood mononuclear cell FMA:86713 15
Spleen FMA:7196 129
T-lymphocyte FMA:62870 61
Other (n = 285)
Bone marrow FMA:9608 31
Colon FMA:14543 135
Epithelial lining fluid FMA:276456 5
Liver FMA:7197 34
Lung FMA:7195 78
Right lung FMA:7309 2
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[13].
Collection and assembly of HIV sequences
The HBSD attempts to contain all available, published
HIV sequences meeting stringent inclusion criteria. For
inclusion in the HBSD, sequences must meet the follow-
ing criteria: (i) be deposited in Genbank; (ii) include
some portion of the HIV env region; (iii) be clonal,
amplified directly from tissue; and (iv) be sampled from
the brain, or sampled from a patient for which the
HBSD already contains brain sequences. We identified
sequences for inclusion both by searching the public
sequence databases–Genbank and the LANL
HIV sequence database–and by identifying publications
that sequenced HIV from the brain. In several cases, we
communicated directly with study authors to encourage
deposition of sequences that had not been previously
submitted to Genbank. Additionally, BLAST alignment
was used to screen for possible contamination with
commonly used lab strains (i.e., ADA, HXB2, JR-CSF,
NL4-3, SF2, BaL, IIIB, MN, SF162, and JR-FL)
Annotation Structure
The HIV Brain Sequence Database contains three
categories of annotations: publication references, patient
and sampling information, and sequence properties
(Table 3). The publication annotations include biblio-
graphic information identifying the study that generated
the sequences. Patient sampling annotations contain
information describing the individual patients, as well as
clinical information at the time of sampling. This infor-
mation was obtained by manual curation of the original
publications and in some cases direct communications
with the study authors. In cases where multiple studies
examined tissue samples from the same patient, the
resulting sequences are linked to the same patient code
to increase statistical power. Sample timepoint annota-
tions describe the patient’s clinical health status, neuro-
cognitive, neuropathological status, CD4 counts, viral
load, and anti-retroviral treatment history at the time of
sampling. Clone and sequence annotations describe the
individual sequences, the tissue from which they were
cloned, and the method of PCR amplification and clon-
ing. This includes the sequence start and end locations
numbered based on alignment to the HXB2 reference
genome, and tissue source coded using terms from a
formal anatomical ontology. Alignment to HXB2 was
performed using the HIV Sequence Locator tool located
at the LANL HIV Sequence Database (http://hiv.lanl.
gov). Currently, amplification and cloning methods
included in the database are: bulk PCR then cloning
(1736 sequences) and limiting-dilution PCR then cloning
(781 sequences). As new sequencing projects are
completed, we hope to expand the database to include
significant numbers of sequences cloned via single gen-
ome amplification.
Annotation of Tissue Type
Annotation of tissue source presented several challenges.
First, the granularity of tissue annotation varied by pub-
lication–we encountered tissue type annotations as gen-
eral as “Brain” and as specific as “White matter of
occipital lobe”. However, within the HBSD a search for
a more general tissue type, such as cerebrum should
also return sequences from sub-parts of the cerebrum,
such as caudate nucleus and putamen. Second, publica-
tions utilize non-standard tissue names that are human-
readable but difficult to parse in a database search. To
address these challenges, we utilized a formal anatomical
ontology, the Foundational Model of Anatomy (FMA) to
code tissue source [14]. The FMA defines terms for
approximately 75,000 human anatomical structures, ran-
ging in scale from biological macromolecules to whole
organ systems. These terms are linked by ontological
relationships defining subpart relationships, allowing the
calculation of transitive closure within the database. In
addition, we assigned sequences into one of four classes:
(i) Brain; (ii) Meninges, choroid plexus, and CSF;
( i i i )B l o o da n dl y m p h o i d ;a n d( i v )O t h e r .M e n i n g e s ,
choroid plexus, and CSF were grouped separately from
Brain because phylogenetic evidence suggests that the
CSF represents an intermediate compartment, contain-
ing virus from both the brain and periphery [8]. “Other”
includes organs such as lung, liver, stomach and pros-
tate, bone marrow, and fluid samples such as lung
epithelial lining fluid.
Annotation of Neurocognitive and Neuropathological
Diagnosis
Neurocognitive and neuropathological status were classi-
fied for each patient at the sampling timepoint, usually
perimortem (Table 4). Neuropathological and neurocog-
nitive disorders can be due either to virus replicating in
the brain or to non-HIV related causes such as toxo-
plasmosis, CMV encephalitis, or CNS lymphoma. Neu-
ropathological status was coded as HIV encephalitis
(HIVE) of varying severity, lymphocytic perivascular
cuffing, or “Other”, specifying the predominant non-
HIV neurological pathology. Neurocognitive diagnosis
was annotated using the nomenclature consensus pub-
lished in Antinori et al, 2007 [4]. We further classified
the HAD diagnosis into mild, moderate, and severe to
capture information included in the publication as mild,
moderate, or severe (most commonly) or MSK scores
(rarely). Additionally, there were several unique cases
that fell outside the AAN or HNRC criteria, but which
we felt were important to annotate within the database.
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tion for patient 196 for the diagnosis of HAD, though
there was evidence for neuropsychiatric disease.”[15].
Given that we lacked the further information to meet
the strict criteria for an ANI or MND diagnosis, we
chose the more general NPI: unknown defined in
Woods et al. 2004 [16]. Diagnoses for patients 1 through
6 stated, “Clinical material was obtained from six HIV-1
infected patients with significant neurological signs and
symptoms requiring image-guided stereotactic brain
biopsy for definitive diagnosis. ... Neurological signs and
symptoms were consistent with the onset of global neu-
rological dysfunction, with clinical evidence supporting
acute rather than chronic HIV-1-associated neurological
disease.”[17]. As an acute diagnosis, this does not fit the
criteria for HAD, so it was annotated in the database as
acute HIV encephalopathy [17].
Design and Implementation
The HBSD structure is sequence-centric and uses NCBI
GI and Genbank accession numbers as identifiers, sim-
plifying correlations with other databases. The database
exists in two forms. The master version is kept intern-
ally as a relational SQL database utilized for sequence
management and curation. This is replicated to an
external interface that uses the Apache Solr search plat-
form to optimize for flexible search and data retrieval.
The search interface (Figure 2) is based on a filtering
paradigm; the user begins with the set of all sequences
and narrows by applying filtering criteria to the
sequence annotations. Filtering criteria are specified by
two means. A faceted search interface presents all values
for categorical annotations, such as tissue class or neu-
rocognitive status. Clicking on a value adds it to the
search criteria and filters for matching sequences. Addi-
tionally, a global search box allows direct entry of search
terms. Multiple searches in the global search box
sequentially add filtering criteria, allowing the construc-
tion of complex searches. Sequences are initially pre-
sented with a default set of annotations, however, users
can select to add or remove columns from the set of all
annotations available. The final filtered set of sequences
and annotations can be downloaded for local analysis in
tab-separated and FASTA formats.
Visualization of the contents of the database
To better understand the highly complex network of
publications, patients, and sequences, we used Cytoscape
to visualize the connections between patients and the
publications that sequenced virus from those patients
(Figure 3). This network visualization demonstrates that,
while most publications examine a unique set of
patients, there is an emerging network of patients from
the Edinburgh MRC HIV Brain and Tissue Bank (coded
as NA#) that are shared among multiple publications.
Additionally, Figure 3 illustrates the dramatic differences
in sequencing depth between patients, and in number of
patients between studies.
Many experimental designs examining compartmenta-
lization or tissue specific effects depend on overlap in the
viral regions sequenced and matched tissue source. In
order to quantify the power of the database to make
these comparisons, we visualized the total number of
across-tissue and within-tissue comparisons possible with
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Figure 1 Sequence coverage of the HIV env gene, numbered according to HXB2. Start and end coordinates are represented, but
sequences are not internally aligned so gaps are not represented. The x-axis shows HXB2 nucleotide numbering with a schematic of the env
gene plotted above. The y-axis shows arbitrary numbering of the plotted sequences.
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Page 5 of 12the current database content (Figure 4). Panel A visua-
lizes, for each tissue pair, how many patients contain
overlapping sequences. Each comparison is ontologically
inclusive–for example entries under Frontal lobe also
consider sequences from White matter of frontal lobe,
Cortex of frontal lobe, etcetera. This visualization reveals
structures within the dataset useful for experimental
design. For example, while a large number of patients
contain overlapping sequences from lymph node and
another tissue, in 8, 11, and 7 patients, respectively, it is
possible to compare frontal lobe to occipital, temporal, or
parietal lobes. Figure 4B is a complementary visualization
counting the number of pairwise patient to patient
comparisons possible within each tissue type. This illus-
trates, for example, that while many patients have over-
lapping sequences from the cerebrum, frontal lobe is a
particularly well-represented tissue. Conversely, though
the database contains sequences from the cerebellum,
there are no across patient comparisons that can be
made. The numbers in both A and B of Figure 4 do not
represent simple sums or permutations, because each
considers sequence overlap. If hypothetical patients A, B,
and C contained full-length env, V3 region, and V5
region sequences, respectively, then only 2 pair-wise
comparisons would be possible (A to B and A to C), not
the 3 given by a simple permutation.
Table 3 Annotation categories
Patient Column Definition
Patient code patient code
Sex gender
Risk factor HIV risk factor
Tissue bank tissue bank distributing samples
Patient year of death patient year of death
Sampling timepoint
Sampling geo-region patient geo-region at time of sampling
Sampling country patient country at time of sampling
Sampling city patient city at time of sampling
Patient age patient age at sampling
Health status patient health status at sampling
Subtype predominant subtype at time of sampling
Drug naïve (ART) has patient had ART
Antiretroviral treatment (ART) patient ART history
Viral load plasma (copies/mL) plasma viral load
Viral load brain (copies/million cells) brain viral load
Viral load lymphoid (copies/million cells) lymphoid viral load
CD4 count (cells/uL) CD4 count
Neurocognitive diagnosis neurocognitive diagnosis
Neuropathological diagnosis neuropathological diagnosis
Giant cells were giant cells present in the brain
Sequence
Genbank accession Genbank accession number
GI Genbank GI number
PubMed ID Pubmed ID for original publicaiton
Sequence length sequence length
Clone name publication assigned clone name
Cloning strategy methods of genome amplification and cloning
Sample tissue class global tissue class (Brain, Blood & Lymphoid, etc...)
Sample tissue name tissue source
Sample tissue FMA code tissue FMA code
Nucleic acid type was proviral DNA or viral RNA sequenced
Start and end coordinates sequence start and end referenced to HXB2
Sequence viral sequence
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The HBSD is a public database designed to facilitate the
assembly of a large meta-dataset of HIV env sequences
that will be invaluable to investigations into the different
patterns of viral evolution in the brain and other tissue
reservoirs, and the relationship of these findings to each
other and to clinical consequences of HIV infection,
particularly development of HAND. The database con-
tains 2517 env sequences cloned from 90 patients and
44 tissues sources. 1272 of these sequences are brain-
derived; the remaining 1245 are derived from blood,
lymph node, spleen, bone marrow, colon, lung, and
other non-brain tissues. The majority of these sequences
are from the V3 region (45%) or near full-length gp120
region (31%), with the remainder being near full-length
env (9%), V4-V5 region (6%),V 1 - V 2r e g i o n( 4 % )a n d
others (5%) (Figure 1). The HBSD is unique compared
to other sequence databases, such as the LANL HIV
Sequence Database or Genbank, because of its specific
focus on HIV in the brain, its stringent inclusion of only
clonal sequences from patients with brain sequences,
and its rigorous curation with detailed clinical, patient,
and HAND annotations.
An HIV env meta-dataset annotated with detailed
clinical information will allow studies that previously
have not been feasible. Combining datasets to increase
the number of sequences and tissue-types increases the
statistical power available. This increased statistical
power can be used to examine questions such as the
genetic variations within env important for macrophage
tropism, which is the primary requirement for HIV
replication in the brain, and nucleotide positions within
env under positive genetic selection during HIV replica-
tion in the CNS. Annotation of neurocognitive status,
neuropathological status, and AIDS progression will
facilitate correlation of viral genotype to clinical pheno-
types, and may help to reveal how viral genotypes affect
the development of HAND.
During the assembly and annotation of the HBSD, we
encountered a number of challenges. Non-uniform tis-
sue coding made consistent database annotation diffi-
cult. To overcome this obstacle, we utilized the FMA
anatomical ontology to convert various tissue source
descriptions into a set of defined terms with ontological
linkages. We encountered several instances of ambigu-
ous patient coding. Because tissue samples are shared
Table 4 Neurocognitive and neuropathological annotations in the database
Neurocognitive Diagnosis Number of Patients Number of Sequences
None 42 739
Acute HIV encephalopathy 6 209
HAD: mild 74 6
HAD: moderate 48
HAD: severe 11 424
HAD: severity not specified 19 810
NPI-unknown 11 0
No diagnosis 7 271
Neuropathological Diagnosis
None 37 369
HIVE: mild 5 276
HIVE: moderate 3 100
HIVE: severe 6 117
HIVE: severity not specified 17 938
Lymphocytic perivascular cuffing 1 31
Other: cerebral atrophy 13 9
Other: CMV encephalitis 15
Other: CNS lymphoma 7 242
Other: necrotizing encephalitis, not HIV-related 1 23
Other: progressive multifocal leukoencephalopathy 2 36
Other: toxoplasmosis 38 3
Other: widespread atherosclerosis 1 87
No diagnosis 12 171
An annotation of “none” indicates a diagnosis of no impairment or neuropathology, whereas “no diagnosis” indicates that clinical annotation information was not
available.
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Page 7 of 12within laboratories, and tissue banks distribute samples
from the same patient to multiple laboratories, viruses
from one patient may be sequenced in multiple publica-
tions. By examining patient annotation data and corre-
sponding with study authors, we identified 3 patients
that were coded differently by multiple studies
(NA118_p5, NA420_p6 and NA21_UK1) and 2 cases of
separate patients that were coded identically by different
studies (NA20 and NA234). Combining sequences from
multiple publications and grouping by patient can
increase the diversity of tissue types and the depth of
sequencing available, while carefully tracking patient
coding can avoid incorrect grouping of non-identical
patients. Many publications included in the HBSD con-
tain duplicate sequences cloned from the same tissue
sample. These duplicate sequences could result either
from PCR resampling in studies utilizing bulk PCR
before cloning, or could represent valid cloning of
copies of a majority viral variant. Fifteen publications
utilized bulk PCR then cloning, 5 utilized limiting dilu-
tion then cloning, and 2 used both approaches, based
on patient. The database contains 490 repeated
s e q u e n c e si n1 6 1g r o u p s .H o w e v e r ,2 1 7o ft h e s e
repeated sequences were obtained by limiting dilution
PCR and therefore are unlikely to represent PCR resam-
pling. Comparison of the distribution of the percentage
of duplicated sequences between bulk PCR and limiting
dilution demonstrated that studies utilizing bulk PCR
then cloning did not show a higher rate of sequence
duplication than those utilizing limiting dilution (data
not shown). Thus duplicated sequences in the database
likely represent appropriate cloning of majority viral
variants.
The HBSD includes several unique datasets, which,
though previously available in the public domain, are
now collected in a standardized annotation format for
meta-analysis. 15 patients included in McCrossan, 2006
[18] are pre-symptomatic, having died from HIV-unre-
lated causes [alcohol/drug overdose (n = 11), cirrhosis
(n = 2), suicide (n = 1), and bronchopneumonia
(n = 1)]. During late-stage AIDS, declining CD4 counts
lead to immune deficiency and reduced selection pres-
sure, allowing viral population expansion that may alter
the distribution of sequence variants. Based on
Figure 2 Search interface of the HBSD. A. Database facets for filtering results. All possible values for each category are presented, along with a
count of the number of sequences for each value. Clicking on a value adds it to the search box (B), filters the results list (C), and updates the
facet list and sequence counts (A). B. Universal search box and search term list. Performs a global search across categories, for example, a search
for “right” returns sequences from both “Right frontal lobe” and “Right lung”. Upon searching, the facet list (A) and results (C) are updated. All
searches and faceting terms applied are placed in the Search Terms box and can be removed individually by clicking the “X” next to a term. C.
Results list. Displays the current list of sequences matching the filters within the Search Terms box (B). Columns can be added or removed
through the Add Columns button. Clicking the checkbox by a sequence adds it to the Selected Sequences box (D). D. Selected Sequences and
Downloads. Clicking the download button presents options to download: (i) Current Results–all sequences matching the search terms, (ii)
Current Selection–all selected sequences in box D, (iii) Entire Collection–the entire HBSD. Downloads consist of a zip file containing a FASTA
formatted file of all sequences, named by Genbank accession number, and a tab-separated file of all selected annotation columns, ready for
import to Excel.
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Page 8 of 12treatment history and year of death, the majority of
patients in the HBSD died prior to the HAART era. 49
out of 90 patients have annotations for antiretroviral
treatment history. Of these 49 patients, 19 are drug
naïve and 30 received antiretroviral drugs. The majority
of antiretroviral treated patients were on pre-HAART
regimens, and 9 received only AZT. Different ART
drugs have differing CNS penetration, affecting selection
pressures on virus replicating in the brain [6]. Addition-
ally, the majority of neurocognitive diagnoses occurred
before the 2007 HNRC consensus document [4] that
defined criteria for asymptomatic neurocognitive impair-
ment (ANI). Future improvement of the quality and
relevance of the database to the current epidemic
requires generating more sequences sampled from the
brains of pre-symptomatic patients at earlier stages of
disease and HAART-treated patients.
Our laboratory will continue to maintain the HBSD as
new sequences are deposited in the public domain. We
expect the HBSD to expand in several ways. New deep
sequencing projects will increase the number of
sequences and expand the diversity of patients, sampling
a wider spectrum of stages of disease and HAART
treatment regimens. Curation of patient coding may
allow us to identify longitudinal sets of sequences
sampled from the periphery, which can be paired with
brain sequences sampled from the same patient at
autopsy. Finally, we chose to focus on env for the initial
database release because it plays a key role in brain
infection and provides a tractable scope for develop-
ment of a highly curated database. As we consider
further database additions,w ew i l lc o n t i n u et ow e i g h
the benefits of inclusion against the resources required
to maintain our high standards of database curation.
Figure 3 Network representation of interconnections between publications, the patients they sequenced, and the number and tissue
classes of sequences available for each patient. The network was constructed using Cytoscape. Black nodes, containing the name of the first
author, represent publications. Publication nodes are connected by edges to the patients they sequenced, represented by clear nodes with
patient code printed at the bottom. In cases where multiple publications sequenced virus from the same patient, multiple publication nodes
connect to a single patient node (patient NA118 in the upper right). Individual HIV sequences for each patient are represented by the colored
dots within patient nodes: Brain-red, Meninges, choroid plexus, and CSF-yellow, Blood and Lymphoid-green, Other-blue. The total number of
sequences for each patient scales the size of the patient node.
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Page 9 of 12Tat and nef are two logical next steps, as these genes
influence brain infection and development of neurocog-
nitive disorders. Drug resistance mutations in pol and
RT would also be a useful addition that will be consid-
ered in the future.
Conclusions
The HBSD is a unique resource for the research com-
munity investigating unique genetic and biological char-
acteristics of HIV in the brain. Though nearly all the
sequences and annotations included were previously
22 1 2 1 1 11 2 2 2
1 111 12 10 10 1 21 1121 111111111 12 1 1 1 1 1 4
5 4 11 21 2 3 2 111
1 11 1
11 1 10 3 2 7 1 5 1 3 114 113 111111 12116 212 1 1 4
3 1 3 11 1 111 21 3 11 1
11 1 1 11
4
13 1211 1 1 11 2 1 12111
11111 11 1 11
33 3 3 2
38 2 38 5 12 1 2 1 13 3 1 19 16 2 36123331 3 11136 4 5 21 36 11 2
12 10 4 10 3 4 22 2 215 3 212221112 4 1 5 11 2
11 1 1 11
5 2 5 4 212 22 3 12 2 4 12 2 3 121112 2 14 11 12 2
8 2 8 4 1 6 4 2 1211 5 1 3 124 6 11 21 12
11 1 1 11 1 1
44 3 44 4 43344 3 4 2 4 111 2 23 11
1 11 1 11 1 111 11111 1 1 1 11 1 1
1 11 1 11 1 111 111111 11 1 11 1 1
11 1 1 1 11 1 1 1 1 1 1 1 111 11 1 1 1
66 3 6 6 66 4 5 44 3 4 1114 22 3 11
55 2 44 4 4333 31 44 1112 1 21 1 1
10 10 5 2176 6 84 5 8 5 3 4 1114 3 2 33 21
33 2 33 3 32 33 3 1 3 1113 21 3 11
44 3 44 4 4333 35 3 4 1114 22 3 11
22 44 3 2 33 21
1 1 11 11 1 1
9 1 91 021 1 1 4 2 44 8 1133 3 834 1114 1 5 4 5 6 4 3 21
55 2 55 5 33 3 3 5 3 5 1113 21 3 11
44 2 44 4 33 3 3 2 4 3 4 1113 22 2 1 1
11 1 11
1111 11 11 16 11
9 1 9 5 1 8 1 66 3 81 4 384 6 1114 123 2 19 1 3 22
11 1
11 3 1 664 5 44 364 6 1114 22 3 11
88 3 8 66 4 5 44 364 6 1114 22 13 3 115 10
22 2 2 2 4 11
44 22 2 1 14 3 1 4 1 3 2 111
33 7 12 8 1 8 1 4 5 11 44374 6 1114 1 6 21 10 21 3 11 1 7 2 10 2
11 1 1 1 1 1
212 11 1 2 2 12 1 11 12 1
10 2 10 1 7 2233 5 12 2 10 1 4 3 2 5 2 3 1113 44 45 11 13 121
2 10 213 4 8 1 9 1 4 5 9 2 4 31 05 6 1114 1 8 5 1 10 38 3 12 131 0 4 11 2
2 221 11 11 22 2 11 11 1
2 10 213 4 8 1 9 1 4 5 9 2 4 31 05 6 1114 1 8 5 11 2 38 3 1 13 4 1 3 11 1 5 11 2 %UDLQ
:KLWHPDWWHURIQHXUD[LV
&HUHEUXP
6HWRIEDVDOJDQJOLD
&DXGDWHQXFOHXV
3XWDPHQ
)URQWDOOREH
:KLWHPDWWHURIIURQWDOOREH
&RUWH[RIIURQWDOOREH
/HIWIURQWDOOREH
5LJKWIURQWDOOREH
0LGGOHIURQWDOJ\UXV
2FFLSLWDOOREH
:KLWHPDWWHURIRFFLSLWDOOREH
&RUWH[RIRFFLSLWDOOREH
/HIWRFFLSLWDOOREH
5LJKWRFFLSLWDOOREH
7HPSRUDOOREH
:KLWHPDWWHURIWHPSRUDOOREH
&RUWH[RIWHPSRUDOOREH
/HIWWHPSRUDOOREH
5LJKWWHPSRUDOOREH
3DULHWDOOREH
/HIWSDULHWDOOREH
5LJKWSDULHWDOOREH
&HUHEHOOXP
/HIWKHPLVSKHUHRIFHUHEHOOXP
5LJKWKHPLVSKHUHRIFHUHEHOOXP
%UDLQVWHP
6SLQDOFRUG
6HWRIPHQLQJHV
&KRURLGSOH[XVRIFHUHEUDOKHPLVSKHUH
&6)
6SOHHQ
/\PSKQRGH
0HVHQWHULFO\PSKQRGH
,QIUDFODYLFXODUO\PSKQRGH
%ORRG
3HULSKHUDOEORRGPRQRQXFOHDUFHOO
7O\PSKRF\WH
%RQHPDUURZ
/XQJ
5LJKWOXQJ
(SLWKHOLDOOLQLQJIOXLG
&RORQ
/LYHU
%
U
D
L
Q






:
K
L
W
H

P
D
W
W
H
U

R
I

Q
H
X
U
D
[
L
V






&
H
U
H
E
U
X
P












6
H
W

R
I

E
D
V
D
O

J
D
Q
J
O
L
D


















&
D
X
G
D
W
H

Q
X
F
O
H
X
V


















3
X
W
D
P
H
Q












)
U
R
Q
W
D
O

O
R
E
H


















:
K
L
W
H

P
D
W
W
H
U

R
I

I
U
R
Q
W
D
O

O
R
E
H


















&
R
U
W
H
[

R
I

I
U
R
Q
W
D
O

O
R
E
H


















/
H
I
W

I
U
R
Q
W
D
O

O
R
E
H


















5
L
J
K
W

I
U
R
Q
W
D
O

O
R
E
H


















0
L
G
G
O
H

I
U
R
Q
W
D
O

J
\
U
X
V












2
F
F
L
S
L
W
D
O

O
R
E
H


















:
K
L
W
H

P
D
W
W
H
U

R
I

R
F
F
L
S
L
W
D
O

O
R
E
H


















&
R
U
W
H
[

R
I

R
F
F
L
S
L
W
D
O

O
R
E
H


















/
H
I
W

R
F
F
L
S
L
W
D
O

O
R
E
H


















5
L
J
K
W

R
F
F
L
S
L
W
D
O

O
R
E
H












7
H
P
S
R
U
D
O

O
R
E
H


















:
K
L
W
H

P
D
W
W
H
U

R
I

W
H
P
S
R
U
D
O

O
R
E
H


















&
R
U
W
H
[

R
I

W
H
P
S
R
U
D
O

O
R
E
H


















/
H
I
W

W
H
P
S
R
U
D
O

O
R
E
H


















5
L
J
K
W

W
H
P
S
R
U
D
O

O
R
E
H












3
D
U
L
H
W
D
O

O
R
E
H


















/
H
I
W

S
D
U
L
H
W
D
O

O
R
E
H


















5
L
J
K
W

S
D
U
L
H
W
D
O

O
R
E
H






&
H
U
H
E
H
O
O
X
P












/
H
I
W

K
H
P
L
V
S
K
H
U
H

R
I

F
H
U
H
E
H
O
O
X
P












5
L
J
K
W

K
H
P
L
V
S
K
H
U
H

R
I

F
H
U
H
E
H
O
O
X
P
%
U
D
L
Q
V
W
H
P
6
S
L
Q
D
O

F
R
U
G
6
H
W

R
I

P
H
Q
L
Q
J
H
V
&
K
R
U
R
L
G

S
O
H
[
X
V

R
I

F
H
U
H
E
U
D
O

K
H
P
L
V
S
K
H
U
H
&
6
)
6
S
O
H
H
Q
/
\
P
S
K

Q
R
G
H






0
H
V
H
Q
W
H
U
L
F

O
\
P
S
K

Q
R
G
H






,
Q
I
U
D
F
O
D
Y
L
F
X
O
D
U

O
\
P
S
K

Q
R
G
H
%
O
R
R
G






3
H
U
L
S
K
H
U
D
O

E
O
R
R
G

P
R
Q
R
Q
X
F
O
H
D
U

F
H
O
O






7

O
\
P
S
K
R
F
\
W
H
%
R
Q
H

P
D
U
U
R
Z
/
X
Q
J






5
L
J
K
W

O
X
Q
J






(
S
L
W
K
H
O
L
D
O

O
L
Q
L
Q
J

I
O
X
L
G
&
R
O
R
Q
/
L
Y
H
U
1
55
10
55
3
6
78
3
703
66
10
28
6
15
10
45
3
10
10
136
10
6
120
300
15
120
17
190
1338
3
55
2714
1
4005
$&RPSDULVRQVDFURVVWLVVXHVZLWKLQSDWLHQWV
%&RPSDULVRQVDFURVV
SDWLHQWVZLWKLQWLVVXHV
Figure 4 Heatmap representation and counts of all possible comparisons between sets of overlapping sequences within the database.
Counts of possible comparisons were generated using 2 custom Perl scripts and SQL statements, then visualized as a heatmap using R. A.
Number of patients for which within-patient comparisons across tissue-types can be made. For pairs of tissues from the X and Y-axis, numbers
indicate the number of patients for which overlapping sequences from both tissues are available. For example, there are 11 patients with
overlapping sequences from both Frontal lobe and Temporal lobe. B. Number of possible pair-wise comparisons across patients within each
tissue type. For each tissue on the Y-axis, numbers indicate the count of possible pair-wise comparisons between patients. For example, there
are 2 patients with overlapping sequences from White matter of neuroaxis, giving 1 possible comparison, and 4 patients with overlapping
sequence from Left occipital lobe, giving 6 possible pair-wise comparisons. Tissue definitions are ontologically inclusive, i.e. Frontal lobe also
includes White matter of frontal lobe, Cortex of frontal lobe, etc. Cells are colored as a heat map accentuating high values, and range from light
yellow (low values) to dark red (high values). Black indicates no comparisons possible.
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Page 10 of 12available in the public domain, the data did not exist in
a well-annotated and accessible format and its assembly
and curation represented a significant hurdle. The
HBSD will be an invaluable resource for studying the
viral genetics of HIV evolution within the brain and
other tissue reservoirs, and the relationship of these
findings to each other and to the development of HIV-
associated neurocognitive disorders.
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